Showing results (151-160 of 237) with videos related to

Sort By:
Pageof 24
Lung Cancer (Amsterdam, Netherlands)|June 27, 2025
Prognostic impact of HNF4α expression in TTF-1-negative non-squamous NSCLC treated with immune checkpoint inhibitorHirokazu Iso, Ryo Ariyasu, Syunsuke Fujishima, et al.
Internal Medicine (Tokyo, Japan)|January 15, 2023
Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic CarcinomaErika Mikami, Shinji Nakamichi, Atsuhiro Nagano, et al.
Clinical Lung Cancer|February 27, 2023
A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS)Akihiko Miyanaga, Hajime Asahina, Satoshi Watanabe, et al.
Cancer Medicine|June 26, 2024
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathwayYasuhiro Kato, Masaru Matsumoto, Natsuki Takano, et al.
Clinical Lung Cancer|November 17, 2020
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)Hajime Asahina, Kentaro Tanaka, Satoshi Morita, et al.
Translational Lung Cancer Research|February 9, 2026
Retrospective study on the tolerability using a four-cycle completion in elderly patients with extensive-stage small-cell lung cancer: a body mass index-based analysisYuto Terashima, Susumu Takeuchi, Yusuke Ishibashi, et al.
Thoracic Cancer|May 19, 2020
Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013BRintaro Noro, Kunihiko Kobayashi, Jiro Usuki, et al.
Lung Cancer (Amsterdam, Netherlands)|March 12, 2004
Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancerMasahiro Ando, Kunihiko Kobayashi, Akinobu Yoshimura, et al.
Molecular Carcinogenesis|October 31, 2003
Reduced transcription of the RB2/p130 gene in human lung cancerHu Xue Jun, Akihiko Gemma, Yoko Hosoya, et al.
Internal Medicine (Tokyo, Japan)|October 1, 2020
Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung CancerShunichi Nishima, Akihiko Miyanaga, Sho Saito, et al.
Pageof 24